{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Phase 1, Multicenter, Open-Label Study of CB-010, a CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy in Patients With Relapsed\/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-1-multicenter-open-label-study-of-cb-010-a-crispr-edited-allogeneic-anti-cd19-car-t-cell-therapy-in-patients-with-relapsed-refractory-b-cell-non-hodgkin-lymphoma-antler\/#breadcrumbitem"}]}